VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
QSIQuantum-Si incorporated
$0.92$182M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

QSI logoQuantum-Si incorporated(QSI)Earnings, Financials & Key Ratios

QSI•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryLife Science Tools and Reagents
AboutQuantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.Show more
  • Revenue$2M-20.3%
  • EBITDA-$93M+10.6%
  • Net Income-$101M-0.3%
  • EPS (Diluted)-0.51+28.2%
  • Gross Margin47.33%-9.5%
  • EBITDA Margin-3813.88%-12.2%
  • Operating Margin-3996.72%-12.6%
  • Net Margin-4160.06%-25.9%
  • ROE-46.52%-12.2%

QSI Key Insights

Quantum-Si incorporated (QSI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Trading at only 0.9x book value

✗Weaknesses

  • ✗Profits declining 22.6% over 5 years
  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Shares diluted 38.1% in last year
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when QSI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

QSI Price & Volume

Quantum-Si incorporated (QSI) stock price & volume — 10-year historical chart

Loading chart...

QSI Growth Metrics

Quantum-Si incorporated (QSI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-46.21%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-3.08%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM24.38%

Return on Capital

10 Years-55.3%
5 Years-36.77%
3 Years-39.56%
Last Year-43.05%

QSI Recent Earnings

Quantum-Si incorporated (QSI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.10+16.7%
$0.12
Rev
$258,000-13.6%
$298,667
Q2 2026
Mar 3, 2026
Metric
Actual
Est
EPS
$0.08+42.9%
$0.14
Rev
$451,000-40.8%
$761,900
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.17-41.7%
$0.12
Rev
$552,000-7.9%
$599,330
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.16+0.0%
$0.16
Rev
$591,000-1.4%
$599,330
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.10vs $0.12+16.7%
$258,000vs $298,667-13.6%
Q2 2026Mar 3, 2026
$0.08vs $0.14+42.9%
$451,000vs $761,900-40.8%
Q4 2025Nov 5, 2025
$0.17vs $0.12-41.7%
$552,000vs $599,330-7.9%
Q3 2025Aug 5, 2025
$0.16vs $0.16+0.0%
$591,000vs $599,330-1.4%
Based on last 12 quarters of dataView full earnings history →

QSI Peer Comparison

Quantum-Si incorporated (QSI) competitors in Life Science Tools and Reagents — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
PACB logoPACBPacific Biosciences of California, Inc.Direct Competitor434.84M1.40-0.773.89%-80.34%-488.45%141.98
CDNA logoCDNACareDx, IncDirect Competitor1.35B26.18-65.4513.79%-1.98%-2.61%0.06
ACMR logoACMRACM Research, Inc.Direct Competitor7.28B109.8780.2015.24%9.48%5.13%0.16
ILMN logoILMNIllumina, Inc.Product Competitor24.6B161.9329.71-0.78%19.43%32.84%0.94
FLGT logoFLGTFulgent Genetics, Inc.Product Competitor535.45M18.00-9.1413.83%-18.75%-5.42%0.00
SEER logoSEERSeer, Inc.Product Competitor95.67M1.74-1.3615.57%-468.74%-26.58%0.09
TMO logoTMOThermo Fisher Scientific Inc.Supply Chain172.66B464.6126.193.91%15.18%13.23%0.76
DHR logoDHRDanaher CorporationSupply Chain125.4B177.1735.152.9%14.89%7.06%0.35

Compare QSI vs Peers

Quantum-Si incorporated (QSI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PACB

Most directly comparable listed peer for QSI.

Scale Benchmark

vs TMO

Larger-name benchmark to compare QSI against a more recognizable public peer.

Peer Set

Compare Top 5

vs PACB, CDNA, ACMR, ILMN

QSI Income Statement

Quantum-Si incorporated (QSI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
00001.08M3.06M2.44M1.85M
Revenue Growth %
-----182.62%-20.34%-46.21%
Cost of Goods Sold
0000594K1.46M1.28M1.11M
COGS % of Revenue
----54.9%47.68%52.67%-
Gross Profit
0▲ 0%
0▲ 0%
0▲ 0%
0▲ 0%
488K▲ 0%
1.6M▲ 227.9%
1.15M▼ 27.9%
741K▲ 0%
Gross Margin %
----45.1%52.32%47.33%40.01%
Gross Profit Growth %
-----227.87%-27.94%-
Operating Expenses
36.62M36.69M96.91M123.84M111.66M110.18M98.51M97.04M
OpEx % of Revenue
----10319.69%3602.88%4044.05%-
Selling, General & Admin
8.52M9.14M50.33M42.3M44.63M50.53M44.75M42.51M
SG&A % of Revenue
----4125.14%1652.55%1837.19%-
Research & Development
28.1M27.55M46.58M72.06M67.03M59.64M53.76M54.53M
R&D % of Revenue
----6194.55%1950.33%2206.86%-
Other Operating Expenses
5K-10K09.48M0000
Operating Income
-36.62M▲ 0%
-36.69M▼ 0.2%
-96.91M▼ 164.1%
-123.84M▼ 27.8%
-111.17M▲ 10.2%
-108.58M▲ 2.3%
-97.36M▲ 10.3%
-96.3M▲ 0%
Operating Margin %
-----10274.58%-3550.56%-3996.72%-5199.84%
Operating Income Growth %
--0.19%-164.12%-27.79%10.23%2.33%10.33%-
EBITDA
-35.84M-35.8M-95.87M-121.26M-107.02M-103.98M-92.91M-91.54M
EBITDA Margin %
-----9890.48%-3400.13%-3813.88%-4942.71%
EBITDA Growth %
-0.12%-167.81%-26.48%11.75%2.84%10.65%13.54%
D&A (Non-Cash Add-back)
780K894K1.04M2.58M4.16M4.6M4.45M4.76M
EBIT
-36.62M-36.69M-94.98M-114.36M-95.96M-108.58M-97.36M-96.3M
Net Interest Income
079K-5K0008.96M1.74M
Interest Income
088K00008.96M1.74M
Interest Expense
09K5K00000
Other Income/Expense
828K78K1.92M-8.6M15.21M7.63M-3.92M-7.59M
Pretax Income
-35.79M▲ 0%
-36.61M▼ 2.3%
-94.99M▼ 159.4%
-132.44M▼ 39.4%
-95.96M▲ 27.5%
-100.95M▼ 5.2%
-101.28M▼ 0.3%
-103.9M▲ 0%
Pretax Margin %
-----8868.76%-3301.21%-4157.68%-5609.94%
Income Tax
0000056K58K-75K
Effective Tax Rate %
0%0%0%0%0%-0.06%-0.06%0.07%
Net Income
-35.8M▲ 0%
-36.61M▼ 2.3%
-94.99M▼ 159.4%
-132.44M▼ 39.4%
-95.96M▲ 27.5%
-101.01M▼ 5.3%
-101.34M▼ 0.3%
-103.82M▲ 0%
Net Margin %
-----8868.76%-3303.04%-4160.06%-5605.89%
Net Income Growth %
--2.28%-159.45%-39.43%27.55%-5.26%-0.33%-3.08%
Net Income (Continuing)
-35.79M-36.61M-94.99M-132.44M-95.96M-101.01M-101.34M-103.82M
Discontinued Operations
00000000
Minority Interest
00000000
EPS (Diluted)
-0.26▲ 0%
-6.81▼ 2519.2%
-1.19▲ 82.5%
-0.95▲ 20.2%
-0.68▲ 28.4%
-0.71▼ 4.4%
-0.51▲ 28.2%
-0.48▲ 0%
EPS Growth %
--2519.23%82.53%20.17%28.42%-4.41%28.17%24.38%
EPS (Basic)
-0.26-6.81-1.19-0.95-0.68-0.71-0.51-
Diluted Shares Outstanding
136.4M5.38M79.58M139.26M141.3M143.2M197.76M216.47M
Basic Shares Outstanding
136.4M5.38M79.58M139.26M141.3M143.2M197.76M216.47M
Dividend Payout Ratio
--------

QSI Balance Sheet

Quantum-Si incorporated (QSI) balance sheet — assets, liabilities & shareholders' equity

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
33.87M37.86M477.17M358.18M266.31M218.01M175.86M134.96M
Cash & Short-Term Investments
32.93M36.91M471.3M351.31M257.74M209.6M162.91M127.34M
Cash Only
32.93M36.91M35.78M84.32M133.86M49.24M21.64M36.2M
Short-Term Investments
00435.52M266.99M123.88M160.36M141.27M91.14M
Accounts Receivable
0000368K1.33M561K203K
Days Sales Outstanding
----124.14159.1184.06577.06
Inventory
00003.94M4.07M3.2M2.19M
Days Inventory Outstanding
----2.42K1.02K909.511.05K
Other Current Assets
826K006.87M4.26M3.01M9.19M5.23M
Total Non-Current Assets
3.54M2.73M26.05M33.3M31.94M29.86M69.75M78.38M
Property, Plant & Equipment
2.55M2M15.88M32.61M30.71M29.05M16.66M15.13M
Fixed Asset Turnover
----0.04x0.11x0.15x0.10x
Goodwill
009.48M00000
Intangible Assets
0000532K000
Long-Term Investments
00000004.69M
Other Non-Current Assets
994K738K690K697K695K808K53.09M63.26M
Total Assets
37.41M▲ 0%
40.59M▲ 8.5%
503.23M▲ 1139.7%
391.49M▼ 22.2%
298.25M▼ 23.8%
247.87M▼ 16.9%
245.61M▼ 0.9%
213.35M▲ 0%
Asset Turnover
----0.00x0.01x0.01x0.01x
Asset Growth %
-8.5%1139.72%-22.2%-23.82%-16.89%-0.91%-13.15%
Total Current Liabilities
1.93M2.75M11.53M15.71M11.61M18.19M23.02M10.71M
Accounts Payable
869K1.33M3.39M3.9M1.77M1.93M1.62M1.79M
Days Payables Outstanding
----1.09K483.41461.73574.36
Short-Term Debt
0000001.84M1.84M
Deferred Revenue (Current)
00000003.22M
Other Current Liabilities
107K579K2.7M88K194K514K19.56M7.08M
Current Ratio
17.57x13.75x41.39x22.81x22.94x11.99x7.64x12.60x
Quick Ratio
17.57x13.75x41.39x22.81x22.60x11.76x7.50x12.40x
Cash Conversion Cycle
----1.46K693.84531.841.05K
Total Non-Current Liabilities
01.75M14.66M17.07M15.02M14.26M2.36M1.9M
Long-Term Debt
01.75M00002.32M1.87M
Capital Lease Obligations
007.22M16.08M13.74M9.25M014.46M
Deferred Tax Liabilities
00000000
Other Non-Current Liabilities
007.45M996K1.28M5.01M34K25K
Total Liabilities
1.93M4.5M26.19M32.78M26.63M32.45M25.38M12.6M
Total Debt
01.75M8.08M17.45M15.3M12.95M4.17M3.71M
Net Debt
-32.93M-35.16M-27.71M-66.87M-118.56M-36.29M-17.47M-32.49M
Debt / Equity
-0.05x0.02x0.05x0.06x0.06x0.02x0.02x
Debt / EBITDA
--------0.04x
Net Debt / EBITDA
-------0.35x
Interest Coverage
--4076.78x-18996.80x-----
Total Equity
35.46M▲ 0%
36.09M▲ 1.8%
477.03M▲ 1221.8%
358.71M▼ 24.8%
271.62M▼ 24.3%
215.42M▼ 20.7%
220.23M▲ 2.2%
200.74M▲ 0%
Equity Growth %
-1.79%1221.83%-24.8%-24.28%-20.69%2.23%-10.03%
Book Value per Share
0.266.715.992.581.921.501.110.93
Total Shareholders' Equity
35.46M36.09M477.03M358.71M271.62M215.42M220.23M200.74M
Common Stock
1K1K14K14K14K18K22K22K
Retained Earnings
-135.63M-172.24M-267.23M-399.67M-495.63M-596.64M-697.98M-719.65M
Treasury Stock
00000000
Accumulated OCI
0000045K-6K-382K
Minority Interest
00000000

QSI Cash Flow Statement

Quantum-Si incorporated (QSI) cash flow — operating, investing & free cash flow history

MetricDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-30.71M-32.57M-66.81M-90.56M-94.04M-87.8M-94.72M-94.2M
Operating CF Margin %
-----8690.94%-2870.99%-3888.22%-
Operating CF Growth %
--6.07%-105.12%-35.54%-3.84%6.64%-7.88%-16.62%
Net Income
-35.79M-36.61M-94.99M-132.44M-95.96M-101.01M-101.34M-103.82M
Depreciation & Amortization
780K894K1.04M2.58M4.16M4.6M4.45M4.76M
Stock-Based Compensation
2.71M1.92M24.92M08.52M8.89M10.77M8.41M
Deferred Taxes
00714K00000
Other Non-Cash Items
501K2K36K35M-7.55M-4.92M-4.03M3.13M
Working Capital Changes
1.09M1.22M1.47M4.3M-3.19M4.64M-4.58M-6.69M
Change in Receivables
0000-368K-1.09M-4.01M5.32M
Change in Inventory
0000286K4.34M-2.01M-1.19M
Change in Payables
-270K536K709K0-1.22M390K0-7K
Cash from Investing
-1.24M-461K-450.94M137.19M143.43M-32.67M-28.32M46.13M
Capital Expenditures
-1.24M-461K-5.76M-10.74M-4.51M-4.58M-2.52M-1.49M
CapEx % of Revenue
----416.82%149.87%103.33%80.4%
Acquisitions
00-4.63M00000
Investments
--------
Other Investing
00-445.17M0-763K-59K00
Cash from Financing
18.22M37.01M516.63M1.91M149K35.88M95.42M47.05M
Debt Issued (Net)
-25K1.69M-1.78M00000
Equity Issued (Net)
18.18M35.31M512.79M2.76M034.79M95.42M46.83M
Dividends Paid
00000000
Share Repurchases
00000000
Other Financing
65K11K5.61M-848K149K1.09M1K222K
Net Change in Cash
-13.73M▲ 0%
3.98M▲ 129.0%
-1.13M▼ 128.3%
48.53M▲ 4414.1%
49.54M▲ 2.1%
-84.62M▼ 270.8%
-27.6M▲ 67.4%
-1.09M▲ 0%
Free Cash Flow
-31.95M▲ 0%
-33.03M▼ 3.4%
-72.58M▼ 119.7%
-101.3M▼ 39.6%
-99.31M▲ 2.0%
-92.38M▲ 7.0%
-97.23M▼ 5.3%
-95.69M▲ 0%
FCF Margin %
-----9178.28%-3020.86%-3991.54%-5166.85%
FCF Growth %
--3.4%-119.7%-39.58%1.97%6.98%-5.26%-0.11%
FCF per Share
-0.23-6.14-0.91-0.73-0.70-0.65-0.49-0.44
FCF Conversion (FCF/Net Income)
0.86x0.89x0.70x0.68x0.98x0.87x0.93x0.92x
Interest Paid
00000000
Taxes Paid
00000000

QSI Key Ratios

Quantum-Si incorporated (QSI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)
-102.35%-37.02%-31.69%-30.45%-41.48%-46.52%-47.35%
Return on Invested Capital (ROIC)
-1593.41%-32.28%-25.06%-37.48%-49.03%-38.24%-36.58%
Gross Margin
---45.1%52.32%47.33%40.01%
Net Margin
----8868.76%-3303.04%-4160.06%-5605.89%
Debt / Equity
0.05x0.02x0.05x0.06x0.06x0.02x0.02x
Interest Coverage
-4076.78x-18996.80x-----
FCF Conversion
0.89x0.70x0.68x0.98x0.87x0.93x0.92x
Revenue Growth
----182.62%-20.34%-46.21%
Related:QSI Dividend History·QSI Revenue History·QSI Price History·QSI P/E History·QSI Financial Ratios·QSI Institutional Holders

QSI SEC Filings & Documents

Quantum-Si incorporated (QSI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 7, 2026·SEC

Material company update

Mar 3, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 3, 2026·SEC

FY 2025

Mar 3, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 5, 2025·SEC

QSI Frequently Asked Questions

Quantum-Si incorporated (QSI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Quantum-Si incorporated (QSI) reported $1.9M in revenue for fiscal year 2025.

Quantum-Si incorporated (QSI) saw revenue decline by 20.3% over the past year.

Quantum-Si incorporated (QSI) reported a net loss of $103.8M for fiscal year 2025.

Dividend & Returns

Quantum-Si incorporated (QSI) has a return on equity (ROE) of -46.5%. Negative ROE indicates the company is unprofitable.

Quantum-Si incorporated (QSI) had negative free cash flow of $95.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in QSI back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

How much would $100/month in QSI be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →